Literature DB >> 29512397

Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms.

Jiraprapa Wipasa1, Romanee Chaiwarith2, Kriangkrai Chawansuntati1, Jutarat Praparattanapan2, Kritsadee Rattanathammethee1, Khuanchai Supparatpinyo1,2.   

Abstract

A major characteristic of immunodeficiency associated with life-threatening intracellular infection in adults is the presence of anti-interferon-γ antibodies. Although little is known about the mechanism underlying this syndrome, it is believed that the antibodies inhibit the activity of downstream signaling pathway of interferon-γ. In this study, the characteristics of these antibodies in patients who presented, or have a history of, intracellular infection and were positive to anti-interferon-γ antibodies were investigated. The antibodies exhibited mainly the IgG1 and the IgG4 subtypes and recognized the C-terminal of the interferon-γ linear epitope containing the KRKR motif, which is required for the biological activity of interferon-γ. The antibodies bound to recombinant interferon-γ with significantly lower avidity than antibodies to a recall antigen, tetanus toxoid, suggesting that the antibodies might have not undergone affinity maturation. The data from this study may provide fundamental information to better understand the properties of anti-interferon-γ antibodies, which can be useful for future studies. Impact statement An increase in the number of immunodeficient patients related to autoantibodies to interferon (IFN)-γ has been observed particularly in East Asian adults. These patients are often presented with opportunistic infections caused by intracellular pathogens, including non-tuberculous mycobacteria (NTM), Cryptococcus neoformans, Penicillium marneffei (now called Talaromyces marneffei), and non-typhoidal Salmonella spp. The mortality rate for this syndrome is relatively high with 32% patients dying at the median time of 25 months after diagnosis. Characterization of these autoantibodies may promote better understanding of the syndrome, an emerging health problem affecting East Asia populations and impeding their welfare and economic development.

Entities:  

Keywords:  Immune deficiency; adult-onset immunodeficiency; anti-interferon-γ antibodies; intracellular organism infection

Mesh:

Substances:

Year:  2018        PMID: 29512397      PMCID: PMC6582397          DOI: 10.1177/1535370218764086

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  9 in total

1.  Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.

Authors:  R S Ying; T Le; W P Cai; Y R Li; C B Luo; Y Cao; C Y Wen; S G Wang; X Ou; W S Chen; S Z Chen; P L Guo; M Chen; Y Guo; X P Tang; L H Li
Journal:  HIV Med       Date:  2020-12       Impact factor: 3.180

2.  Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.

Authors:  Jing Guo; Bing-Kun Li; Tian-Min Li; Fang-Lin Wei; Yu-Jiao Fu; Yan-Qing Zheng; Kai-Su Pan; Chun-Yang Huang; Cun-Wei Cao
Journal:  Mycopathologia       Date:  2019-08-31       Impact factor: 2.574

3.  Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Authors:  Han-Po Shih; Jing-Ya Ding; Junel Sotolongo Bellón; Yu-Fang Lo; Pei-Han Chung; He-Ting Ting; Jhan-Jie Peng; Tsai-Yi Wu; Chia-Hao Lin; Chia-Chi Lo; You-Ning Lin; Chun-Fu Yeh; Jiun-Bo Chen; Ting-Shu Wu; Yuag-Meng Liu; Chen-Yen Kuo; Shang-Yu Wang; Kun-Hua Tu; Chau Yee Ng; Wei-Te Lei; Yu-Huan Tsai; Jou-Han Chen; Ya-Ting Chuang; Jing-Yi Huang; Félix A Rey; Hung-Kai Chen; Tse-Wen Chang; Jacob Piehler; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Exp Med       Date:  2022-07-14       Impact factor: 17.579

Review 4.  Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

Authors:  Aristine Cheng; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2022-01       Impact factor: 14.290

5.  Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency.

Authors:  Umpa Yasamut; Tanchanok Wisitponchai; Vannajan Sanghiran Lee; Montarop Yamabhai; Kuntalee Rangnoi; Weeraya Thongkum; Koollawat Chupradit; Chatchai Tayapiwatana
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

Review 6.  Minireview: Insights into anti-interferon-γ autoantibodies.

Authors:  Kriangkrai Chawansuntati; Kritsadee Rattanathammethee; Jiraprapa Wipasa
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-11

7.  Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.

Authors:  Umpa Yasamut; Weeraya Thongkum; Sutpirat Moonmuang; Supachai Sakkhachornphop; Romanee Chaiwarith; Jutarat Praparattanapan; Jiraprapa Wipasa; Kriangkrai Chawansuntati; Khuanchai Supparatpinyo; Ethan Lai; Chatchai Tayapiwatana
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

8.  Human autoantibodies underlying infectious diseases.

Authors:  Anne Puel; Paul Bastard; Jacinta Bustamante; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2022-03-23       Impact factor: 14.307

9.  Characterization of Anti-Interferon-γ Antibodies in HIV-Negative Patients Infected With Disseminated Talaromyces marneffei and Cryptococcosis.

Authors:  Wen Zeng; Ye Qiu; Shudan Tang; Jianquan Zhang; Mianluan Pan; Xiaoning Zhong
Journal:  Open Forum Infect Dis       Date:  2019-10-11       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.